T 1149/09 (Vaccinia virus formulation/BAVARIAN NORDIC) of 24.10.2013

European Case Law Identifier: ECLI:EP:BA:2013:T114909.20131024
Date of decision: 24 October 2013
Case number: T 1149/09
Petition for review of: -
Application number: 02796552.4
IPC class: A61K 47/18 A61K 47/32 A61K 47/26 A61K 39/275
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Poxvirus-containing compositions and process for their preparation
Applicant name: Bavarian Nordic A/S
Opponent name: TRANSGENE S.A.
Sanofi Pasteur, Inc.
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 108 European Patent Convention Art 56 European Patent Convention R 101(1)Rules of procedure of the Boards of Appeal Art 13(1)
Keywords: Inventive step - main request, auxiliary requests 2 to 4 (no)
Admissibility of appeal of opponent 02
Admissibility of appeal - statement of grounds (not filed)
Catchword: -
Cited cases: G 0002/98 T 0377/95 T 0333/97
Citing cases: T 0499/09

Order

For these reasons it is decided that:

1. The appeal of opponent 02 is rejected as inadmissible.

2. The decision under appeal is set aside and the patent is revoked.